COMPLETED

Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Despite advances in effective psoriatic disease treatment, the disease still has a serious impact on mental health and well-being of millions of patients. Up to 20.7% of patients report poor mental health, compared to 7.1% of the general population. Mental health treatment involves a combination of medication and talk therapy to address such issues. However, there is increasing evidence that optimizing behaviors such as sleep, physical activity, stress, and nutrition are critical components in improving mental health too. Numerous online health programs have evolved to help patients optimize such behaviors but very little exists for patients with psoriatic diseases. The "Immune Strength" 12 week program utilizes online electronic coaching (eCoaching) with weekly access to a wellness professional to provide a low-cost, high-touch, personalized intervention that patients can access 24/7. In conjunction with traditional clinical care, the goal of this program is to leverage the convenience, affordability, scalability and effectiveness of an online eCoaching program to improve key physical behaviors, thereby reducing the mental health burden experienced by psoriatic disease patients.

Official Title

Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases

Quick Facts

Study Start:2022-10-27
Study Completion:2025-04-14
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05571696

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient of Cleveland Clinic
  2. * Adults (=18 years of age)
  3. * Diagnosis of psoriasis or psoriatic arthritis by a board certified physician.
  4. * PHQ9 score between 5 and 20
  5. * Computer and internet access
  6. * A valid email address
  7. * Able to speak \& read English
  8. * Able to understand \& sign informed consent
  1. * PHQ9 score \> 20
  2. * History of major depressive disorder
  3. * Currently receiving psychotherapy for major depressive disorder (MDD), anxiety or psychotic disorder
  4. * On a wait-list for psychotherapeutic treatment
  5. * Received treatment for a severe psychiatric illness in the previous 6 months
  6. * Demonstrate a notable suicidal risk at study visit

Contacts and Locations

Principal Investigator

Elaine Husni, MD
PRINCIPAL_INVESTIGATOR
The Cleveland Clinic

Study Locations (Sites)

The Cleveland Clinic
Cleveland, Ohio, 44195
United States

Collaborators and Investigators

Sponsor: Elaine Husni

  • Elaine Husni, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-27
Study Completion Date2025-04-14

Study Record Updates

Study Start Date2022-10-27
Study Completion Date2025-04-14

Terms related to this study

Keywords Provided by Researchers

  • Psoriatic Arthritis
  • Psoriasis
  • Mental Health
  • Well being

Additional Relevant MeSH Terms

  • Arthritis, Psoriatic
  • Psoriasis